453.34
Precedente Chiudi:
$465.72
Aprire:
$465.72
Volume 24 ore:
440.93K
Relative Volume:
0.96
Capitalizzazione di mercato:
$12.74B
Reddito:
$2.23B
Utile/perdita netta:
$418.30M
Rapporto P/E:
33.71
EPS:
13.45
Flusso di cassa netto:
$579.82M
1 W Prestazione:
-1.16%
1M Prestazione:
+46.77%
6M Prestazione:
+33.25%
1 anno Prestazione:
+14.56%
Medpace Holdings Inc Stock (MEDP) Company Profile
Nome
Medpace Holdings Inc
Settore
Industria
Telefono
(513) 579-9911
Indirizzo
5375 MEDPACE WAY, CINCINNATI, OH
Confronta MEDP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MEDP
Medpace Holdings Inc
|
453.34 | 13.00B | 2.23B | 418.30M | 579.82M | 13.45 |
![]()
TMO
Thermo Fisher Scientific Inc
|
483.76 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
203.90 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
633.05 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
117.15 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
185.39 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-29 | Downgrade | UBS | Neutral → Sell |
2025-07-23 | Downgrade | TD Cowen | Hold → Sell |
2025-06-24 | Iniziato | Barclays | Equal Weight |
2025-04-22 | Downgrade | William Blair | Outperform → Mkt Perform |
2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
2025-03-24 | Iniziato | Leerink Partners | Market Perform |
2024-10-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-10-14 | Iniziato | Redburn Atlantic | Buy |
2024-09-27 | Downgrade | UBS | Buy → Neutral |
2024-09-25 | Downgrade | Jefferies | Buy → Hold |
2024-08-01 | Iniziato | Truist | Hold |
2024-05-29 | Iniziato | TD Cowen | Buy |
2024-05-28 | Iniziato | Mizuho | Buy |
2024-04-23 | Aggiornamento | Jefferies | Hold → Buy |
2024-03-18 | Iniziato | Deutsche Bank | Hold |
2024-02-15 | Aggiornamento | UBS | Neutral → Buy |
2023-10-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2023-05-08 | Aggiornamento | Guggenheim | Neutral → Buy |
2022-10-27 | Aggiornamento | UBS | Sell → Neutral |
2022-09-07 | Iniziato | UBS | Sell |
2022-05-24 | Iniziato | Guggenheim | Neutral |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2020-10-02 | Aggiornamento | Truist | Hold → Buy |
2020-06-08 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
2020-05-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2020-04-30 | Aggiornamento | SunTrust | Sell → Hold |
2020-04-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
2020-03-17 | Downgrade | SunTrust | Hold → Sell |
2020-01-27 | Downgrade | SunTrust | Buy → Hold |
2018-10-31 | Aggiornamento | SunTrust | Hold → Buy |
2018-09-17 | Iniziato | SunTrust | Hold |
2018-07-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2017-11-01 | Downgrade | William Blair | Outperform → Mkt Perform |
2017-09-29 | Iniziato | Raymond James | Mkt Perform |
2017-07-10 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Medpace Holdings Inc Borsa (MEDP) Ultime notizie
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034 - GlobeNewswire Inc.
Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know - Yahoo Finance
Can Medpace Holdings Inc. scale operations efficientlyQuarterly Earnings Report & Step-by-Step Swing Trade Plans - 선데이타임즈
What makes Medpace Holdings Inc. stock price move sharplyPortfolio Value Report & Weekly High Potential Alerts - thegnnews.com
Multi Factor Analysis Ranks Medpace Holdings Inc. as Strong BuyTrade Volume Summary & Consistent Income Trade Recommendations - sundaytimes.kr
Medpace Volume Surges 63.22% to $240M Ranks 485th in Market Activity as Institutional Capital Flows In - AInvest
Medpace Shares Rally 3.55% on $250M Volume Ranking 406th as Liquidity-Driven Strategy Surpasses Benchmark by 137.53 - AInvest
Earnings Not Telling The Story For Medpace Holdings, Inc. (NASDAQ:MEDP) After Shares Rise 34% - simplywall.st
Medpace slips as UBS cuts to Sell despite strong Q2 results - MSN
Should You Buy Medpace (MEDP) After Golden Cross? - MSN
Can Medpace Holdings Inc. Rally Enough to Break EvenSector Based Breakout Stock Forecast Issued - beatles.ru
Trendline Breach Raises Concern for Medpace Holdings Inc. InvestorsWeekly Hot Picks With Buy Confidence Released - metal.it
Medpace: Return Of The Mack, With Double-Digit Revenue Growth (NASDAQ:MEDP) - Seeking Alpha
Medpace Surprises with Double-Digit Revenue Growth in Q2 2025 - AInvest
Should I hold or sell Medpace Holdings Inc. stock in 2025Free Stock Market Real-Time Monitoring - Jammu Links News
How volatile is Medpace Holdings Inc. stock compared to the marketRapid market gains - Jammu Links News
Published on: 2025-08-04 02:37:58 - Jammu Links News
What catalysts could drive Medpace Holdings Inc. stock higher in 2025Capitalize on momentum-driven opportunities - Jammu Links News
Does Medpace Holdings Inc. stock perform well during market downturnsInvest in stocks with strong fundamentals - Jammu Links News
What drives Medpace Holdings Inc. stock priceDiscover stocks with explosive upside potential - Jammu Links News
Is Medpace Holdings Inc. stock overvalued or undervaluedMarket-leading profit generation - Jammu Links News
What institutional investors are buying Medpace Holdings Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Is it the right time to buy Medpace Holdings Inc. stockBuild wealth with professional market analysis - Jammu Links News
Medpace Holdings Inc. Rebound Backed by Sentiment ShiftBuy Signal Based on Chart Analysis Confirmed - beatles.ru
Identifying reversal signals in Medpace Holdings Inc.Real Time Stock Movement Analysis Indicates Breakout - metal.it
How does Medpace Holdings Inc. generate profit in a changing economyDaily Trading Picks With High Returns - Jammu Links News
Have Medpace Holdings Insiders Been Selling Stock? - 富途牛牛
Has Medpace Holdings Inc. Stock Ever Crashed Historical Volatility ReviewChart Driven High Reward Trading Setup Presented - beatles.ru
Medpace Hldgs Insider Sells $21.9M Worth of Stock - AInvest
How Medpace Holdings Inc. stock performs during market volatilityShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Institutional Tools Highlight Unusual Flow in Medpace Holdings Inc.Swing Trading Plan With Smart Signals in Review - metal.it
Medpace general counsel Ewald sells $1.35m in stock - Investing.com
Medpace general counsel Ewald sells $1.35m in stock By Investing.com - Investing.com South Africa
Insider Selling at Medpace Holdings: Distinguishing Routine Moves from Red Flags - AInvest
Medpace stock slips as UBS cuts to Sell (MEDP:NASDAQ) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - TradingView
MEDP: UBS Downgrades Medpace Holdings, Raises Price Target | MED - GuruFocus
Medpace stock rating downgraded to Sell by UBS on ambitious targets - Investing.com Nigeria
Decoding Insider Selling at Medpace Holdings: A Strategic Investment Analysis - AInvest
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Yahoo Finance
What Makes Medpace (MEDP) a New Strong Buy Stock - sharewise.com
Medpace Holdings Inc Azioni (MEDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medpace Holdings Inc Azioni (MEDP) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
EWALD STEPHEN P | General Counsel & Corp. Secy. |
Jul 28 '25 |
Sale |
450.00 |
3,000 |
1,350,000 |
10,343 |
BURWIG SUSAN E | Exec. VP, Operations |
Jul 28 '25 |
Sale |
450.14 |
7,500 |
3,376,050 |
57,500 |
Troendle August J. | CEO |
Jul 28 '25 |
Sale |
451.69 |
48,487 |
21,901,093 |
962,615 |
GEIGER JESSE J | President |
Jul 24 '25 |
Option Exercise |
107.93 |
41,801 |
4,511,582 |
78,304 |
GEIGER JESSE J | President |
Jul 24 '25 |
Sale |
453.11 |
41,801 |
18,940,451 |
36,503 |
Brady Kevin M. | CFO & Treasurer |
Jul 24 '25 |
Option Exercise |
57.94 |
12,000 |
695,280 |
18,000 |
Brady Kevin M. | CFO & Treasurer |
Jul 24 '25 |
Sale |
454.23 |
12,000 |
5,450,760 |
6,000 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):